Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
11 - 20 out of 51Page size: 10
Sort by: Title
  1. Published

    Enteral feeding without pancreatic stimulation.

    Kaushik, N., Pietraszewski, M., Holst, Jens Juul & O'Keefe, S. J. D., 2005, In: Pancreas. 31, 4, p. 353-9 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Erythromycin antagonises the deceleration of gastric emptying by glucagon-like peptide-1 (GLP)-1 and unmasks its insulinotropic effect in healthy subjects

    Meier, J. J., Kemmeries, G., Holst, Jens Juul & Nauck, M. A., 2005, In: Diabetes. 54, p. 2212-2218

    Research output: Contribution to journal › Journal article › Research

  3. Published

    Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects

    Meier, J. J., Kemmeries, G., Holst, Jens Juul & Nauck, M. A., Jul 2005, In: Diabetes. 54, 7, p. 2212-8 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Evidence for an endocrine pancreatico-gastric axis: The role of pancreatic polypeptide in gastric emptying and short term metabolic control

    Schmidt, P. T., Näslund, E., Grybäck, P., Jacobsson, H., Holst, Jens Juul, Hilsted, L. & Hellström, P. M., 2005, In: J. Clin. Endocrinol. Metab.. 90, p. 5241-5246

    Research output: Contribution to journal › Journal article › Research

  5. Published

    Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes

    Torekov, Signe Sørensen, Larsen, L. H., Glümer, C., Borch-Johnsen, K., Jørgensen, T., Holst, Jens Juul, Madsen, O. D., Hansen, Torben & Pedersen, Oluf Borbye, 2005, In: Diabetes. 54, 7, p. 2261-5 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Evidence of an association between the Arg72-allele of the peptide YY (PYY) and increased risk of type 2 diabetes

    Torekov, S. S., Larsen, L. H., Glümer, C., Borch-Johnsen, K., Jørgensen, T., Holst, Jens Juul, Madsen, O. D., Hansen, T. & Pedersen, O., 2005, In: Diabetes. 54, p. 2261-2265

    Research output: Contribution to journal › Journal article › Research

  7. Published

    Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

    Fehse, F., Trautmann, M., Holst, Jens Juul, Halseth, A. E., Nanyakkara, N., Nielsen, L., Fineman, M. S. D., Kim, D. D. & Nauck, M. A., 2005, In: J. Clin. Endocrinol. Metab.. 90, p. 5991-5997

    Research output: Contribution to journal › Journal article › Research

  8. Published

    Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

    Fehse, F., Trautmann, M., Holst, Jens Juul, Halseth, A. E., Nanayakkara, N., Nielsen, L. L., Fineman, M. S., Kim, D. D. & Nauck, M. A., Nov 2005, In: The Journal of clinical endocrinology and metabolism. 90, 11, p. 5991-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1?

    Holst, Jens Juul & Deacon, Carolyn F., 2005, In: Diabetologia. 48, p. 612-615

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    GLP-1 receptor argonists for the treatment of diabetes

    Holst, Jens Juul, 2005, In: International Diabetes Monitor. 17, p. 11-18

    Research output: Contribution to journal › Journal article › Research

Previous 1 2 3 4 5 6 Next

ID: 4207